Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2101
Pennant Park Investment Corp
PNNT
$197M
| $6.37M | ﹤0.01% |
1,836,639
| – | – |
2022 Q4
14 quarters
|
|
2102
Templeton Emerging Markets Income Fund
TEI
$288M
| $6.37M | ﹤0.01% |
944,656
+143,518
| +18% | +$921K |
2013 Q2
52 quarters
|
|
2103
Ouster
OUST
$2.14B
| $6.36M | ﹤0.01% |
101,712
+36,202
| +55% | +$1.22M |
2024 Q2
8 quarters
|
|
2104
Pacira BioSciences
PCRX
$1.45B
| $6.33M | ﹤0.01% |
249,350
+11,770
| +5% | +$278K |
2013 Q2
52 quarters
|
|
2105
Capri Holdings
CPRI
$1.93B
| $6.33M | ﹤0.01% |
340,607
-1,596
| -0.5% | -$30.6K |
2013 Q2
52 quarters
|
|
2106
Absci
ABSI
$1.91B
| $6.32M | ﹤0.01% |
544,933
+434,813
| +395% | +$2.45M |
2024 Q2
8 quarters
|
|
2107
Safety Insurance
SAFT
$1.53B
| $6.31M | ﹤0.01% |
84,274
+3,427
| +4% | +$250K |
2013 Q2
52 quarters
|
|
2108
Enerpac Tool Group
EPAC
$2.08B
| $6.3M | ﹤0.01% |
175,698
-7,074
| -4% | -$248K |
2013 Q2
52 quarters
|
|
2109
Albemarle Corp Depositary Shares
ALB.PRA
$1.89B
| $6.3M | ﹤0.01% |
113,800
-25,000
| -18% | -$1.77M |
2024 Q1
9 quarters
|
|
2110
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.12B
| $6.27M | ﹤0.01% |
157,441
+46,561
| +42% | +$1.95M |
2025 Q1
5 quarters
|
|
2111
iShares MSCI Saudi Arabia ETF
KSA
$553M
| $6.26M | ﹤0.01% |
167,768
-15,145
| -8% | -$588K |
2021 Q4
18 quarters
|
|
2112
Lakeland Financial Corp
LKFN
$1.48B
| $6.25M | ﹤0.01% |
101,334
-6,885
| -6% | -$415K |
2013 Q2
52 quarters
|
|
2113
Allspring Income Opportunities Fund
EAD
$356M
| $6.25M | ﹤0.01% |
961,400
-83,094
| -8% | -$543K |
2013 Q2
52 quarters
|
|
2114
Agios Pharmaceuticals
AGIO
$1.82B
| $6.24M | ﹤0.01% |
168,153
+16,723
| +11% | +$507K |
2015 Q2
44 quarters
|
|
2115
abrdn Asia-Pacific Income Fund
FAX
$529M
| $6.22M | ﹤0.01% |
422,875
+35,279
| +9% | +$519K |
2013 Q2
52 quarters
|
|
2116
PIMCO Corporate & Income Strategy Fund
PCN
$818M
| $6.17M | ﹤0.01% |
516,606
+28,080
| +6% | +$333K |
2023 Q4
10 quarters
|
|
2117
First Advantage
FA
$3.71B
| $6.14M | ﹤0.01% |
340,374
+192,280
| +130% | +$2.79M |
2021 Q3
19 quarters
|
|
2118
RH
RH
$2.78B
| $6.1M | ﹤0.01% |
37,004
-106
| -0.3% | -$14.6K |
2013 Q2
52 quarters
|
|
2119
Herbalife
HLF
$1.37B
| $6.08M | ﹤0.01% |
462,462
-87,269
| -16% | -$1.2M |
2013 Q2
52 quarters
|
|
2120
Happen Inc
HAPN
$1.79B
| $6.08M | ﹤0.01% |
293,084
+30,063
| +11% | +$512K |
2015 Q1
45 quarters
|
|
2121
Summit Therapeutics
SMMT
$12.8B
| $6.07M | ﹤0.01% |
416,847
-109,256
| -21% | -$1.94M |
2023 Q1
13 quarters
|
|
2122
PIMCO High Income Fund
PHK
$769M
| $6.06M | ﹤0.01% |
1,300,222
+51,603
| +4% | +$238K |
2020 Q1
25 quarters
|
|
2123
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.7B
| $6.05M | ﹤0.01% |
73,188
+51
| +0.1% | +$4.22K |
2013 Q2
52 quarters
|
|
2124
VanEck Gold Miners ETF
GDX
$23.7B
| $6.04M | ﹤0.01% |
80,000
| – | – |
2025 Q2
4 quarters
|
|
2125
Eaton Vance Senior Floating-Rate Fund
EFR
$301M
| $6.03M | ﹤0.01% |
569,237
+8,975
| +2% | +$94.3K |
2013 Q2
52 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.